Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3.
Tsuji
Takahiro
T
Takatsu
Noritaka
N
Nosaka
Kisato
K
Kawakita
Toshiro
T
Nanri
Tomoko
T
Horikawa
Kentaro
K
Mitsuya
Hiroaki
H
Asou
Norio
N
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D001752:Blast Crisis / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000628:therapy; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D003561:Cytarabine / Q000008:administration & dosage; D004172:Diplopia / Q000209:etiology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000628:therapy; D008297:Male; D010255:Paranasal Sinus Neoplasms / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000628:therapy; D019009:Proto-Oncogene Proteins c-kit; D033581:Stem Cell Transplantation; D014178:Translocation, Genetic; D014184:Transplantation, Homologous; D051941:fms-Like Tyrosine Kinase 3
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; C497970:FLT3 protein, human; D019009:Proto-Oncogene Proteins c-kit; D051941:fms-Like Tyrosine Kinase 3